As the Senior Director of Pharmaceutical Sciences (AD, CMC, Tech Ops, and Supply Chain) and Manufacturing, Eric Chapdelaine is responsible for running all facets of those departments for Genprex, Inc. Eric has a proven management track record and over 14 years of experience driving growth in the pharmaceutical and biotech industry. Prior to joining Genprex, Eric was Director of Quality Control and Analytical Development at Cognate BioServices, responsible for management and oversight of a large Quality Control and Analytical Development staff (45+ people) and multiple laboratories in a Cell and Gene Therapy CDMO facility. At Cognate, he led all QC and Analytical functions such as Analytical Development, Qualification, Validation, and Tech Transfer. Previously, he served as Quality Control Manager of Specifications at Alnylam Pharmaceuticals, where he led as Specification Committee Chairperson and authored CMC-related sections of regulatory filings for the first ever approved RNAi therapeutic for commercial use. He spent the prior 6 years at Sanofi Genzyme holding several corporate management positions. Eric has recently been awarded as a Global Goodwill Ambassador for his volunteering work with such organizations as Birthday Wishes, Pets of the Homeless, and the ASPCA. He earned a MS degree in Chemistry from Vanderbilt University and while at UMass Amherst getting his BS degree in Biochemistry and Molecular Biology, he was awarded Time Magazine Student of the Year (Massachusetts).